Selective serotonin reuptake inhibitors and risk of acute pancreatitis: A population-based case-control study

Journal of Clinical Psychopharmacology

Volumn 27, Issue 3, 2007, Pages 259-262

  Nørgaard, Mette ^a,b,c   Jacobsen, Jacob ^a   Gasse, Christiane ^a,b   Pedersen, Lars ^a   Mortensen, Preben Bo ^b   Sørensen, Henrik Toft ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DENMARK; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SAMPLING;

ACUTE DISEASE; ADULT; AGED; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; RISK; SEROTONIN UPTAKE INHIBITORS;

EID: 34248597919     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318058a9c3     Document Type: Article

References (19)

1. Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. JAMA. 2002;287:203-209.
2. RxList. The Internet Drug Index. Rancho Sante Fe, CA: RxList Inc; 2006.
3. Steer ML. Pathogenesis of acute pancreatitis. Ann Rev Med. 1988;39:95-105.
4. Underwood TW, Frye CB. Drug-induced pancreatitis. Clin Pharm. 1993;12:440-448.
5. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med. 1994;330:1198-1210.
6. Eland IA, Sturkenboom MJ, Wilson JH, et al. Incidence and mortality of acute pancreatitis between 1985 and 1995. Scand J Gastroenterol. 2000;35:1110-1116.
7. Swaroop VS, Suresh TC. Severe acute pancreatitis. JAMA. 2004;291:2865-2868.
8. Marshall JB. Acute pancreatitis. A review with an emphasis on new developments. Arch Intern Med. 1993;153:1185-1198.
9. Wilmink T, Frick TW. Drug-induced pancreatitis. Drug Saf. 1996;14:406-423.
10. Eland IA, van Puijenbroek EP, Sturkenboom MJ, et al. Drug-associated acute pancreatitis: twenty-one years of spontaneous reporting in The Netherlands. Am J Gastroenterol. 1999;94:2417-2422.
11. Munk EM, Pedersen L, Floyd A, et al. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study. Am J Gastroenterol. 2004;99:884-888.
12. Kvande KT, Madsen S. Selective serotonin uptake inhibitors and pancreatitis. Tidsskr Nor Laegeforen. 2001;121:177-178.
13. Spigset O, Hagg S, Bate A. Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions. Int Clin Psychopharmacol. 2003;18:157-161.
14. Lancashire RJ, Cheng K, Langman JS. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther. 2003;17:887-893.
15. Szklo M, Nieto FJ. Epidemiology Beyond the Basics. 1st ed. Gaithersburg, MD: Aspen Publishers; 2000.
16. Schneeweiss S. Sensitivity analysis and external adjustment for un-measured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf. 2006;15:291-303.
17. Weinstock MA, Colditz GA, Willett WC, et al. Recall (report) bias and reliability in the retrospective assessment of melanoma risk. Am J Epidemiol. 1991;133:240-245.
18. Floyd A, Pedersen L, Nielsen GL, et al. Secular trends in incidence and 30-day case fatality of acute pancreatitis in North Jutland County, Denmark. A register-based study from 1981-2000. Scand J Gastroenterol. 2002;12:1461-1465.
19. Blomgren KB, Sundstrom A, Steineck G, et al. A Swedish case-control network for studies of drug-induced morbidity - acute pancreatitis. Eur J Clin Pharmacol. 2002;58:275-283.